or
forgot password
  • cancer clinical trials in rochester, NY

  • Arsenic Trioxide in Treating Men With Germ Cell Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Safety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
    University of Rochester Medical Center
    Rochester, New York 14642
    Venous Thrombosis, Surgery, Deep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism, Abdominal Surgery
    OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
    Interlakes Oncology & Hematology, P.C.
    Rochester, New York 14623
    Pancreatic Cancer
    BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer
    University of Rochester Medical Center
    Rochester, New York 14642
    Stage IV Renal Cell Cancer, Recurrent Renal Cell Cancer
    S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Breast Cancer
    S0124: Cisplatin Combined With Either Irinotecan or Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lung Cancer
    PS-341 (VELCADEâ„¢) Versus High-Dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    Rochester General Hospital, Lipson Cancer Blood Center

    Trial Locations
    Rochester General Hospital, Lipson Cancer Blood Center
    University of Rochester Medical Center, James P. Wilmot Cancer Center
    Multiple Myeloma
    A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
    University of Rochester Cancer Center
    Rochester, New York 14642
    Myelodysplastic Syndromes
    A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies
    University of Rochester
    Rochester, New York 14642
    Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell
    Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Prostate Cancer
    S0125, Chemotherapy, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Cachexia, Lymphoma, Lymphoproliferative Disorder, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
    James P. Wilmot Cancer Center at the University of Rochester Medical Center
    Rochester, New York 14642
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Head and Neck Cancer
    Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases
    S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Bladder Cancer, Urethral Cancer
    Study of the Physical and Emotional Needs of Parents Caring for Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Leukemia
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    James P. Wilmot Cancer Center

    Trial Locations
    James P. Wilmot Cancer Center
    Pluta Cancer Center
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lung Cancer
    Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Waldenstrom's Macroglobulinemia
    Interlakes Oncology/Hematology PC

    Trial Locations
    Interlakes Oncology/Hematology PC
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Lymphoma
    VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
    University of Rochester Medical Center
    Rochester, New York 14642
    Mantle Cell Lymphoma
    A Study of PS-341 Given to Patients With Multiple Myeloma Who Experienced Progressive Disease After Receiving Dexamethasone in M34101-039
    Rochester General Hospital

    Trial Locations
    Rochester General Hospital
    University of Rochester Medical Center, James P. Wilmot Cancer Center
    Multiple Myeloma
    Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Metastatic Cancer, Sarcoma
    Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoproliferative Disorder
    Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor
    S0222: Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center

    Trial Locations
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Highland Hospital of Rochester
    Lung Cancer
    Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood Transfusions
    U. Of Rochester Medical Center
    Rochester, New York 14642
    Anemia, Sickle Cell
    Bortezomib in Treating Patients With Recurrent or Refractory Extensive-Stage Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma
    University of Rochester Medical Center
    Rochester, New York 14642
    Non-Hodgkin's Lymphoma
    Phase II CT-2103/Carboplatin in Ovarian Cancer
    Upstate New York Cancer Research and Education Foundation
    Rochester, New York 98104
    Ovarian Neoplasm
    Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lymphoma
    Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY(1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC-GMT - 5 hours, EST), or speak with your personal physician.
    Rochester, New York
    Lung Neoplasms
    Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
    Univ. of Rochester HVTN CRS
    Rochester, New York 14642
    HIV Infections
    Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma
    University of Rochester
    Rochester, New York 14642
    Adult Rhabdomyosarcoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
    Lipson Cancer and Blood Center at Rochester General Hospital
    Rochester, New York 14621
    Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis
    SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL)
    Upstate NY Cancer Research & Education Foundation, Inc. - Interlakes Oncology/Hematology
    Rochester, New York 14623
    Non-Hodgkin's Lymphoma
    Carboplatin, Vincristine, and Temozolomide in Treating Children With Progressive and/or Symptomatic Low-Grade Glioma
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Brain and Central Nervous System Tumors
    FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Colorectal Cancer
    Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent Anaplastic Large Cell Lymphoma
    University of Rochester
    Rochester, New York 14642
    Anaplastic Large-Cell Lymphoma
    Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
    University of Rochester Cancer Center
    Rochester, New York 14642
    Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Lung Neoplasms
    Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer
    Upstate NY Cancer R&E Foundation
    Rochester, New York 14623
    Esophagitis, Pneumonitis, Non-Small Cell Lung Carcinoma
    Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary CNS Germ Cell Tumor
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Brain Tumor, Central Nervous System Tumor
    S0342: Paclitaxel, Carboplatin, and Cetuximab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Interlakes Oncology & Hematology, P.C.
    Rochester, New York 14623
    Non-Small Cell Lung Cancer
    Non-small Cell Lung Cancer Study US75 (Z-PACT)
    James P. Wilmot Cancer Center
    Rochester, New York 14642
    Non Small Cell Lung Carcinoma
    Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer
    James P. Wilmot Cancer Center at University of Rochester Medical Center
    Rochester, New York 14642
    Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Interlakes Oncology & Hematology, P.C.
    Rochester, New York 14623
    Carcinoma, Non-Small-Cell Lung